Literature DB >> 9399641

Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction.

P J Coffer1, A van Puijenbroek, B M Burgering, M Klop-de Jonge, L Koenderman, J L Bos, W Kruijer.   

Abstract

The binding of insulin to its receptor initiates multiple signal transduction pathways regulating such diverse processes as proliferation, differentiation, glucose transport, and glycogen metabolism. The STAT-family of transcription factors has been demonstrated to play a critical role in gene induction by a variety of hemopoietic cytokines and hormones. Furthermore, constitutive activation of STATs is observed in transformed cells. Here we describe activation of a transcriptional complex binding to a consensus STAT-transcriptional element in response to insulin challenge. This complex is induced rapidly after tyrosine autophosphorylation of the insulin receptor, and is sustained for several hours. Supershift analysis of the insulin-induced complex reveals that it specifically contains the transcription factor Stat3. DAN binding of this complex is inhibited by pre-incubation with tyrosine, but not serine/threonine protein kinase inhibitors, whereas transcriptional activation is inhibited by both. Utilising a dominant negative mutant of p21ras we demonstrate that both insulin-induced Stat3 DNA-binding and also transactivation do not require p21ras. Furthermore, although previous studies have suggested a role for MAP kinases (ERKs) and PI-3K in STAT activation, utilising the specific MEK inhibitor PD098059 and the PI-3K inhibitor wortmannin, we demonstrate that activation of ERKs or PI-3K are not required for insulin induced Stat3 phosphorylation or transactivation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399641     DOI: 10.1038/sj.onc.1201429

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Pregnancy-associated plasma protein (PAPP)-A expressed in the mammary gland controls epithelial cell proliferation and differentiation.

Authors:  Makoto Nakasato; Hitoshi Kohsaka; Tetsuya Mizutani; Gen Watanabe; Kazuyoshi Taya; Kentaro Nagaoka
Journal:  Endocrine       Date:  2012-08-17       Impact factor: 3.633

2.  Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes.

Authors:  J Kawashima; K Tsuruzoe; H Motoshima; A Shirakami; K Sakai; Y Hirashima; T Toyonaga; E Araki
Journal:  Diabetologia       Date:  2003-02-11       Impact factor: 10.122

3.  RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth.

Authors:  Weizhou Zhang; Cong S Zong; Ulrich Hermanto; Pablo Lopez-Bergami; Ze'ev Ronai; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

4.  Differential regulation of STAT family members by glycogen synthase kinase-3.

Authors:  Eléonore Beurel; Richard S Jope
Journal:  J Biol Chem       Date:  2008-06-11       Impact factor: 5.157

5.  A systems-level interrogation identifies regulators of Drosophila blood cell number and survival.

Authors:  Richelle Sopko; You Bin Lin; Kalpana Makhijani; Brandy Alexander; Norbert Perrimon; Katja Brückner
Journal:  PLoS Genet       Date:  2015-03-06       Impact factor: 5.917

6.  Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes.

Authors:  Yasuo Ido; Albert Duranton; Fan Lan; Karen A Weikel; Lionel Breton; Neil B Ruderman
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

Review 7.  JAK-STAT signaling and myocardial glucose metabolism.

Authors:  Miguel A Frias; Christophe Montessuit
Journal:  JAKSTAT       Date:  2013-09-27

8.  Dipeptidyl peptidase-4 is associated with myogenesis in patients with adolescent idiopathic scoliosis possibly via mediation of insulin sensitivity.

Authors:  Zhicheng Dai; Bingchuan Xue; Leilei Xu; Zhenhua Feng; Zhichong Wu; Yong Qiu; Zezhang Zhu
Journal:  J Orthop Surg Res       Date:  2022-02-09       Impact factor: 2.359

9.  Critical analysis of the potential for targeting STAT3 in human malignancy.

Authors:  Noah D Peyser; Jennifer R Grandis
Journal:  Onco Targets Ther       Date:  2013-07-30       Impact factor: 4.147

Review 10.  Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Inflamm Res       Date:  2021-09-02       Impact factor: 4.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.